Iterum shares plunge 19% as FDA needs more review time for sulopenem NDA
09 April 2021 - 10:50PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From Apr 2024 to May 2024
Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From May 2023 to May 2024